T86.850

Clinical Causes: Immune system response: The body's immune system may recognize the transplanted intestine as foreign and initiate an attack. Inadequate immunosuppressive therapy: Not taking the prescribed medications properly or insufficient immunosuppression can lead to rejection. Genetic factors: Some individuals may have immune responses that are more likely to target the transplanted organ. Previous transplant history: Those who have undergone multiple transplants may have a higher risk. Infections: Certain infections can stimulate immune activity and potentially contribute to rejection. Timing: Rejection can occur at any time, but is more common within the first few months after transplantation.

Key Symptoms: Abdominal pain or discomfort Fever and chills Nausea or vomiting Diarrhea or changes in bowel movements Unintentional weight loss Fatigue or weakness Swelling or tenderness near the transplant site Signs of organ failure, such as abnormal blood tests

Diagnosis Path: Blood tests: To evaluate organ function and detect signs of rejection. Biopsy: A tissue sample from the intestine to look for immune cells attacking the organ. Imaging tests: Such as ultrasound or CT scans to check for complications. Monitoring of symptoms and clinical signs: Close observation for any changes that suggest rejection. Laboratory markers: Tests for specific antibodies that may indicate immune response against the transplant.

Treatment Protocols: Immunosuppressive medications: Adjusting doses or adding new medications to reduce immune attack. Corticosteroids: Often used to decrease inflammation and immune response. Treatment of underlying infections: To prevent further immune activation. Plasmapheresis or intravenous immunoglobulin (IVIG): In severe cases to remove or block harmful antibodies. Supportive care: Managing symptoms and maintaining nutritional status. Possible retransplantation: In cases where rejection cannot be controlled or organ failure occurs.